Stegh, A. (2015). METB-12 CANCER-ASSOCIATED IDH1 PROMOTES GROWTH AND RESISTANCE TO TARGETED THERAPIES IN THE ABSENCE OF MUTATION. Neuro Oncol.
استشهاد بنمط شيكاغوStegh, Alexander. "METB-12 CANCER-ASSOCIATED IDH1 PROMOTES GROWTH AND RESISTANCE TO TARGETED THERAPIES IN THE ABSENCE OF MUTATION." Neuro Oncol 2015.
MLA استشهادStegh, Alexander. "METB-12 CANCER-ASSOCIATED IDH1 PROMOTES GROWTH AND RESISTANCE TO TARGETED THERAPIES IN THE ABSENCE OF MUTATION." Neuro Oncol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.